Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
A brand new mobile immunotherapy method that mixes options of a well known customized remedy utilized in blood cancers and tumor-infiltrating lymphocyte (TIL)...
Affected person traits and medical predictorsThe research included 500 lung most cancers sufferers and 500 wholesome controls. Key traits resembling age, intercourse, smoking...
